Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-23.40M.
ENTERPRISE VALUE (EV)
$-23.40M
Kyntra Bio, Inc.
Market Cap
$24.47M
Enterprise Value (EV)
$-23.40M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Kyntra Bio, Inc. (KYNB) | $24.47M | $-23.40M |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.59M | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.30M | $26.03M |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.43M | $14.23M |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.12M | $68.17M |
| LeonaBio, Inc. (LONA)vs › | $21.73M | N/A |
| InspireMD, Inc. (NSPR)vs › | $27.82M | $14.64M |
| Modular Medical, Inc. (MODD)vs › | $20.40M | $16.76M |
| aTyr Pharma, Inc. (ATYR)vs › | $28.73M | $23.87M |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.96M | $19.82M |
Market Cap
$24.47M
Total Debt
$0.00
Cash
$47.87M
Enterprise Value
$-23.40M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
